MSB 3.21% $1.13 mesoblast limited

Ann: Remestemcel-L FDA Fast Track Designation for COVID-19 ARDS, page-369

  1. 12,359 Posts.
    lightbulb Created with Sketch. 1105
    Hi,
    On the plus side we have now a much larger indication with the trial for ARDS.
    Which apart from treatments we are not paying for.
    I very much doubt kids are dying I think we are still treating compassionately.
    Hope so.
    No point looking in the rear view mirror, you cant see what upfront.


    I just wonder when Novatis got a call up.?

    Aloha.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.